Hepatitis C DNA vaccine - Merck & Co.Alternative Names: HCV DNA vaccine - Merck & Co.
Latest Information Update: 06 Sep 2019
Price : $50 *
At a glance
- Originator Merck & Co
- Class Antivirals; DNA vaccines; Hepatitis C vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 31 Aug 2019 Brickell Biotech has merged with Vical to form Brickell Biotech Inc, and subsequently Brickell Biotech changed its name to Brickell Subsidiary
- 04 Nov 2017 No recent reports of development identified for research development in Hepatitis-C in USA (IM)
- 30 Mar 2010 Research phase development is ongoing in USA